Bayer announces 2012 recipients of bayer hemophilia awards program Full Text
BayNews International, 07/11/2012
Bayer HealthCare today announced the 2012 recipients of the Bayer Hemophilia Awards Program (BHAP). This year, the company awards a total of approximately 2.3 million USD in funding to 15 recipients in nine countries. BHAP is the largest program of its kind in hemophilia, funding innovative research and educational initiatives around the world. As such, BHAP is a key program in Hemophilia Solutions, Bayer's program of commitment to research, treatment and education in hemophilia.